☆ 4.4 Review

Recent progress on the mutations of SARS-CoV-2 spike protein and suggestions for prevention and controlling of the pandemic

INFECTION GENETICS AND EVOLUTION (2021)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies

Ivan Mercurio et al.

Summary: The recent COVID-19 pandemic has led to a global health emergency and calls for the scientific community to identify new tools for diagnosis and treatment. In silico analysis has provided insights into conformational changes of the SARS-CoV-2 spike protein and potential antibodies that could target it to prevent virus invasion into human cells. This analysis also offers guidance for developing new vaccines and treatments based on targeting the spike protein.

CELLULAR AND MOLECULAR LIFE SCIENCES (2021)

Add to Collection

Review Infectious Diseases

Genetic comparison among various coronavirus strains for the identification of potential vaccine targets of SARS-CoV2

Navpreet Kaur et al.

Summary: The ongoing COVID-19 pandemic has become a global public health emergency, prompting urgent research into therapeutic and preventive interventions. Global efforts are focused on understanding the origin and evolutionary history of SARS-CoV2 to develop potential treatments and prevention strategies.

INFECTION GENETICS AND EVOLUTION (2021)

Add to Collection

Article Infectious Diseases

Higher binding affinity of furin for SARS-CoV-2 spike (S) protein D614G mutant could be associated with higher SARS-CoV-2 infectivity

Anwar Mohammad et al.

Summary: The study on D614G substitution in the SARS-CoV-2 virus during the COVID-19 pandemic reveals that the substitution introduces structural flexibility and decreases thermal stability, enhancing binding affinity with furin, potentially resulting in a more virulent strain.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Cell Biology

AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells

Shuai Wang et al.

Summary: This study found that AXL may serve as a novel receptor for SARS-CoV-2, playing an important role in promoting viral infection of the human respiratory system. AXL expression level is closely correlated with SARS-CoV-2 S level and could be a potential target for future clinical intervention strategies.

CELL RESEARCH (2021)

Add to Collection

Article Infectious Diseases

Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020

Antonin Bal et al.

Summary: The study reported the strategy leading to the first detection of the variant of concern 202012/01 (VOC) in France, by screening for mutations such as Delta H69/Delta V70 associated with VOC and identifying co-occurring mutations like S:N501Y.

EUROSURVEILLANCE (2021)

Add to Collection

Article Infectious Diseases

Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020

Kathy Leung et al.

Summary: Two new lineages of SARS-CoV-2 with the N501Y mutation in the receptor-binding domain of the spike protein have spread rapidly in the United Kingdom. The 501Y lineage without amino acid deletion Delta 69/Delta 70 was estimated to be 10% more transmissible than the 501N lineage, while the 501Y lineage with amino acid deletion Delta 69/Delta 70 was estimated to be 75% more transmissible than the 501N lineage.

EUROSURVEILLANCE (2021)

Add to Collection

Article Gastroenterology & Hepatology

Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19

Yun Kit Yeoh et al.

Summary: This study found that the gut microbiome composition was significantly altered in patients with COVID-19 compared to non-COVID-19 individuals, regardless of medication received. Certain gut commensals known for their immunomodulatory potential were underrepresented in patients and remained low even after disease resolution. Additionally, the altered gut microbiome composition correlated with disease severity and elevated levels of inflammatory cytokines and blood markers.

GUT (2021)

Add to Collection

Review Microbiology

SARS-CoV-2, the pandemic coronavirus: Molecular and structural insights

Swapnil B. Kadam et al.

Summary: The outbreak of COVID-19 marked the third spillover of an animal coronavirus to humans in the last 20 years, likely originating from bats and possibly transmitted to humans via unknown intermediate host (potentially a pangolin). The causative pathogen, SARS-CoV-2, shares genetic similarities with bat and pangolin coronaviruses in terms of protein structure and genome, suggesting a zoonotic origin.

JOURNAL OF BASIC MICROBIOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19

Tyler N. Starr et al.

Summary: Research has found that mutations in the receptor binding domain (RBD) of SARS-CoV-2 may potentially escape the action of the REGN-COV2 cocktail, providing important information for interpreting mutations observed during viral surveillance.

SCIENCE (2021)

Add to Collection

Editorial Material Multidisciplinary Sciences

SARS-CoV-2 spillover events

Peng Zhou et al.

SCIENCE (2021)

Add to Collection

Article Multidisciplinary Sciences

Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape

Paul-Albert Koenig et al.

Summary: In this study, new neutralizing nanobodies targeting the SARS-CoV-2 spike protein were developed, showing enhanced neutralizing activity through engineering technology and successfully suppressing the emergence of escape mutants. The findings suggest that nanobodies can neutralize through receptor binding competition and also render virions noninfectious.

SCIENCE (2021)

Add to Collection

Article Multidisciplinary Sciences

Immunological characteristics govern the transition of COVID-19 to endemicity

Jennie S. Lavine et al.

Summary: The study suggests that infection-blocking immunity to SARS-CoV-2 wanes rapidly while disease-reducing immunity is long-lived. The model predicts that once reaching endemic phase, SARS-CoV-2 may become no more virulent than the common cold. However, a different outcome is predicted for an emergent coronavirus causing severe disease in children.

SCIENCE (2021)

Add to Collection

Article Cell Biology

Enhanced SARS-CoV-2 neutralization by dimeric IgA

Zijun Wang et al.

Summary: The IgA response to SARS-CoV-2 was characterized in a cohort of 149 convalescent individuals after COVID-19 diagnosis. IgA responses in plasma generally correlated with IgG responses, and B cells producing IgM, IgG, and IgA were derived from common progenitor cells. Notably, IgA dimers were found to be 15 times more potent than IgA monomers against SARS-CoV-2, suggesting their potential value for protection and vaccine efficacy.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection

Review Virology

Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike Protein

Lee Makowski et al.

Summary: This paper proposes the hypothesis that viral binding to cell-surface integrins may contribute to the high infectivity and widespread extra-pulmonary impacts of SARS-CoV-2. The emergence of an RGD sequence in the receptor-binding domain of the spike protein is suggested to be potentially responsible for this. The interactions between virions and integrins could dysregulate signaling pathways and lead to tissue damage, with implications for various clinical outcomes.

VIRUSES-BASEL (2021)

Add to Collection

Article Cell Biology

D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction

Sophie M-C Gobeil et al.

Summary: The study found that the mutation variant G614 of SARS-CoV-2 leads to significant changes in the protein structure, resulting in altered positioning ratio of RBD, which may have implications for vaccine design.

CELL REPORTS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape

Qianqian Li et al.

Summary: The 501Y.V2 variants of SARS-CoV-2 with multiple mutations are rapidly spreading from South Africa to other countries, showing reduced susceptibility to neutralizing antibodies and potential compromise of monoclonal antibodies and vaccines. Enhanced infectivity in murine ACE2-overexpressing cells suggests the possibility of transmission to mice.

CELL (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

Piyada Supasa et al.

Summary: Research on the UK-dominant variant B.1.1.7 shows that it is harder to neutralize than the parental virus, but widespread escape from antibodies or monoclonal antibodies has not been observed yet.

CELL (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

Daming Zhou et al.

Summary: The race to develop vaccines against SARS-CoV-2 variants, such as B.1.1.7, B.1.351, and P.1, is ongoing as these variants have mutations in the spike protein, potentially leading to immune escape. A structure-function analysis of B.1.351 revealed tighter ACE2 binding and widespread evasion from monoclonal antibody neutralization, particularly driven by the E484K mutation.

CELL (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 spike D614G change enhances replication and transmission

Bin Zhou et al.

Summary: Research has shown that the D614G substitution in the spike protein of SARS-CoV-2 leads to increased binding and replication potential in humans, as well as significantly higher replication and transmissibility in different animal models, providing an explanation for the global prevalence of this variant in the COVID-19 pandemic.

NATURE (2021)

Add to Collection

Article Multidisciplinary Sciences

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7

Pengfei Wang et al.

Summary: The COVID-19 pandemic has had global repercussions, with promising vaccines and monoclonal antibody therapies. However, newly detected variants of SARS-CoV-2 present challenges to these treatment options.

NATURE (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 evolution during treatment of chronic infection

Steven A. Kemp et al.

Summary: Chronic infection with SARS-CoV-2 can lead to viral evolution and increased resistance to neutralizing antibodies in immunosuppressed individuals treated with convalescent plasma. During convalescent plasma therapy, there were significant shifts in the viral population structure and sensitivity, suggesting strong selection pressure on the virus during treatment.

NATURE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies

Rita E. Chen et al.

Summary: The study analyzed antibody neutralization activity against a panel of authentic isolates and chimeric SARS-CoV-2 variants, showing significantly reduced neutralizing activity against the B.1.351 variant first identified in South Africa. Antibodies targeting the receptor-binding domain and N-terminal domain, monoclonal antibodies, convalescent sera, and mRNA vaccine-induced immune sera exhibited decreased inhibitory activity against viruses with an E484K spike mutation, suggesting a need for updated monoclonal antibodies or vaccine adjustments to prevent loss of protection against emerging variants.

NATURE MEDICINE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

Constantinos Kurt Wibmer et al.

Summary: The SARS-CoV-2 virus in the B.1.351 variant discovered in South Africa can evade neutralization by most antibodies when expressed, but does not affect binding by convalescent plasma. This suggests the potential for reinfection with antigenically distinct variants and predicts reduced efficacy of spike-based vaccines.

NATURE MEDICINE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Sixteen novel lineages of SARS-CoV-2 in South Africa

Houriiyah Tegally et al.

Summary: The study identified 16 new lineages of SARS-CoV-2 in South Africa between March and August 2020, with unique mutations not found elsewhere. Three lineages (B.1.1.54, B.1.1.56, and C.1) dominated during the country's first wave, accounting for approximately 42% of all infections. The C.1 lineage, with 16 nucleotide mutations including the D614G spike protein change, became the most geographically widespread by August 2020. Genomic surveillance played a crucial role in identifying the 501Y.V2 variant in South Africa in December 2020.

NATURE MEDICINE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera

Xuping Xie et al.

Summary: The study found that human sera from recipients of the BNT162b2 vaccine can neutralize SARS-CoV-2 viruses containing key spike mutations from the newly emerged UK and SA variants.

NATURE MEDICINE (2021)

Add to Collection

Letter Multidisciplinary Sciences

Transmission of SARS-CoV-2 via fomite, especially cold chain, should not be ignored

Weilong Ji et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Add to Collection

Review Biology

Gut microbiota in antiviral strategy from bats to humans: a missing link in COVID-19

Jia Luo et al.

Summary: Bats are potential natural reservoirs for SARS-CoV-2 virus and other harmful viruses, with evidence showing that gut microbiota remodeling in bats plays a role in immune tolerance to viruses. Understanding the influence of gut microbiota in bats has provided insights into its potential impact on COVID-19 disease in humans.

SCIENCE CHINA-LIFE SCIENCES (2021)

Add to Collection

Article Multidisciplinary Sciences

Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution

Shuyuan Zhang et al.

Summary: This study identified structural similarities and differences between the spikes of bat and pangolin coronaviruses compared to SARS-CoV-2, with implications for receptor binding and cell entry. Critical residues in the receptor-binding domain play a key role in determining the activity of the spikes from different coronaviruses.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity

Seiya Ozono et al.

Summary: The naturally occurring mutations of SARS-CoV-2 spike protein can affect cell entry, with the D614G mutation resulting in increased cell entry and maintaining susceptibility to neutralization by antisera against prototypic viruses. Further global surveillance is needed to understand the transmissibility of SARS-CoV-2 among humans.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Biology

The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types

Zharko Daniloski et al.

Summary: A novel variant of SARS-CoV-2 virus with mutation D614G has been found to be more effective at transducing human cells and showing increased infectivity in human cells compared to the wild-type variant.

ELIFE (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Bioinformatics prediction of B and T cell epitopes within the spike and nucleocapsid proteins of SARS-CoV2

Reham M. Dawood et al.

Summary: This study focuses on identifying immunogenic targets for better vaccine development and immunotherapy of SARS CoV2 infection. The research revealed a deletion of key amino acid residues in the S protein, affecting the structure and function of the protein. A set of B and T cell epitopes were proposed based on immune response data for post-infection immunity.

JOURNAL OF INFECTION AND PUBLIC HEALTH (2021)

Add to Collection

Review Biochemistry & Molecular Biology

The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play

Pedro F. N. Souza et al.

Summary: This review discusses the sequence and structural differences of S proteins among SARS-CoV, MERS-CoV, and SARS-CoV-2, highlighting their importance in infection, transmission, and evolution. It also explores the mutations in the receptor-binding domain (RBD) of these coronaviruses, as well as the mutations in the S protein of new isolates of SARS-CoV-2.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)

Add to Collection

Article Infectious Diseases

Is there a need to widely prescribe antibiotics in patients hospitalized with COVID-19?

F. Moretto et al.

Summary: An analysis of COVID-19 patients hospitalized in the Infectious Diseases Department of Dijon University Hospital in France found that although 78% of patients received antibiotic therapy, those who received antibiotics had more severe presentation at admission. However, antibiotic therapy was not significantly associated with patient outcomes.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Multidisciplinary Sciences

Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice

Raoul De Gasparo et al.

Summary: The bispecific IgG1-like molecule CoV-X2 can simultaneously bind two independent sites on the RBD, prevent spike binding to ACE2, neutralize SARS-CoV-2 and its variants, and protect mice from disease in a mouse model of SARS-CoV-2 infection. This demonstrates the feasibility and efficacy of targeting non-overlapping RBD epitopes with IgG-like bispecific antibodies.

NATURE (2021)

Add to Collection

Article Multidisciplinary Sciences

Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma

Sandile Cele et al.

Summary: The study compared the neutralization of non-VOC and 501Y.V2 VOC variants using plasma from COVID-19 patients in South Africa. It found that plasma from individuals infected during the first wave effectively neutralized the first-wave virus variant, while plasma from those infected in the second wave effectively neutralized the 501Y.V2 variant.

NATURE (2021)

Add to Collection

Editorial Material Multidisciplinary Sciences

The emerging plasticity of SARS-CoV-2

Kevin D. McCormick et al.

SCIENCE (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity

Annachiara Rosa et al.

Summary: The study shows that the SARS-CoV-2 spike protein binds biliverdin and bilirubin, products of heme metabolism, at a nanomolar affinity. Controlling access to a dominant epitope on the spike protein can be achieved through an allosteric mechanism involving recruitment of a metabolite and relocation of a gating loop on the N-terminal domain.

SCIENCE ADVANCES (2021)

Add to Collection

Review Microbiology

Lactiplantibacillus plantarum as a Potential Adjuvant and Delivery System for the Development of SARS-CoV-2 Oral Vaccines

Julio Villena et al.

Summary: This study highlights the potential of LAB-based vaccines in fighting against COVID-19 and emphasizes the important role of Lactiplantibacillus plantarum in improving mucosal antiviral defenses, expressing heterologous proteins, and successfully expressing viral antigens.

MICROORGANISMS (2021)

Add to Collection

Article Infectious Diseases

SARS-CoV-2 mutation 614G creates an elastase cleavage site enhancing its spread in high AAT-deficient regions

Chandrika Bhattacharyya et al.

Summary: Researchers found that the 614G subtype of SARS-CoV-2 spreads significantly faster in Europe and North America compared to East Asia, partly due to the introduction of a novel neutrophil elastase (ELANE) cleavage site on the Spike protein of the G mutant. A deficiency in AAT makes it easier for the 614G virus to enter host cells.

INFECTION GENETICS AND EVOLUTION (2021)

Add to Collection

Letter Infectious Diseases

SARS-CoV-2 spike E484K mutation reduces antibody neutralisation

Sonia Jangra et al.

LANCET MICROBE (2021)

Add to Collection

Article Multidisciplinary Sciences

Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice

Alexander A. Cohen et al.

Summary: The study developed nanoparticles displaying the receptor binding domain (RBD) of SARS-CoV-2 and other animal coronaviruses, which induced cross-reactive antibody responses in mice. Immunization with mosaic RBD nanoparticles resulted in superior neutralization of heterologous viruses, providing a potential strategy for simultaneous protection against multiple coronaviruses.

SCIENCE (2021)

Add to Collection

Article Multidisciplinary Sciences

Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans

Bas B. Oude Munnink et al.

Summary: Animal experiments have shown that various animals can be infected by SARS-CoV-2, with evidence of animal-to-human transmission within mink farms. Investigation into mink farm outbreaks revealed that the virus was initially introduced by humans and has since evolved, causing transmission between mink farms. Despite enhanced biosecurity measures and culling, transmission occurred between farms in three large clusters with unknown modes of transmission, resulting in a high percentage of infections among mink farm residents and employees.

SCIENCE (2021)

Add to Collection

Article Medicine, General & Internal

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Roujian Lu et al.

LANCET (2020)

Add to Collection

Review Medicine, Research & Experimental

Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2

Sairaj Satarker et al.

ARCHIVES OF MEDICAL RESEARCH (2020)

Add to Collection

Article Biochemistry & Molecular Biology

A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2

Maopeng Wang et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)

Add to Collection

Article Multidisciplinary Sciences

Cell entry mechanisms of SARS-CoV-2

Jian Shang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Add to Collection

Review Infectious Diseases

Recent progress on the diagnosis of 2019 Novel Coronavirus

Linzhu Ren et al.

TRANSBOUNDARY AND EMERGING DISEASES (2020)

Add to Collection

Review Biochemistry & Molecular Biology

COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives

Jiumeng Sun et al.

TRENDS IN MOLECULAR MEDICINE (2020)

Add to Collection

Article Virology

Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts

Xiaofeng Zhai et al.

JOURNAL OF VIROLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Genomic Epidemiology, Evolution, and Transmission Dynamics of Porcine Deltacoronavirus

Wan-Ting He et al.

MOLECULAR BIOLOGY AND EVOLUTION (2020)

Add to Collection

Letter Virology

A Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-nCoV) Potentially Related to Viral Transmissibility

Qiong Wang et al.

VIROLOGICA SINICA (2020)

Add to Collection

Review Chemistry, Multidisciplinary

Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19

Yuan Huang et al.

ACTA PHARMACOLOGICA SINICA (2020)

Add to Collection

Editorial Material Biochemistry & Molecular Biology

Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear

Nathan D. Grubaugh et al.

CELL (2020)

Add to Collection

Letter Infectious Diseases

Genetic evolution analysis of 2019 novel coronavirus and coronavirus from other species

Chun Li et al.

INFECTION GENETICS AND EVOLUTION (2020)

Add to Collection

Article Multidisciplinary Sciences

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

Lihong Liu et al.

NATURE (2020)

Add to Collection

Article Multidisciplinary Sciences

Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in Spain

Joaquim Segales et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Add to Collection

Editorial Material Multidisciplinary Sciences

Low genetic diversity may be an Achilles heel of SARS-CoV-2

Jason W. Rausch et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Add to Collection

Article Multidisciplinary Sciences

Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates

Joana Damas et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Add to Collection

Article Multidisciplinary Sciences

Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, transmission, and response to reexposure in cats

Angela M. Bosco-Lauth et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Add to Collection

Article Multidisciplinary Sciences

In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges

Beata Turonova et al.

SCIENCE (2020)

Add to Collection

Article Multidisciplinary Sciences

Neuropilin-1 is a host factor for SARS-CoV-2 infection

James L. Daly et al.

SCIENCE (2020)

Add to Collection

Article Multidisciplinary Sciences

Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

Ludovico Cantuti-Castelvetri et al.

SCIENCE (2020)

Add to Collection

Review Virology

COVID-19 pandemic: current knowledge about the role of pets and other animals in disease transmission

Mulugeta Kiros et al.

VIROLOGY JOURNAL (2020)

Add to Collection

Article Virology

Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection

Chang Li et al.

VIRUS RESEARCH (2020)

Add to Collection

Article Virology

Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein

Nouredine Behloul et al.

VIRUS RESEARCH (2020)

Add to Collection

Article Virology

Host Immune Response Driving SARS-CoV-2 Evolution

Rui Wang et al.

VIRUSES-BASEL (2020)

Add to Collection

Article Multidisciplinary Sciences

Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide

Sandra Isabel et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Cell Biology

A Single-Cell RNA Expression Map of Human Coronavirus Entry Factors

Manvendra Singh et al.

CELL REPORTS (2020)

Add to Collection

Review Immunology

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses

Zeinab Abdelrahman et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Article Cell Biology

Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2

Lili Wu et al.

CELL DISCOVERY (2020)

Add to Collection

Review Virology

A Crowned Killer's Resume: Genome, Structure, Receptors, and Origin of SARS-CoV-2

Shichuan Wang et al.

VIROLOGICA SINICA (2020)

Add to Collection

Article Immunology

Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients

Anita S. Iyer et al.

SCIENCE IMMUNOLOGY (2020)

Add to Collection

Letter Medicine, General & Internal

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host

Bina Choi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Review Medical Laboratory Technology

Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome

Sonia Villapol

TRANSLATIONAL RESEARCH (2020)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity

Lizhou Zhang et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Review Immunology

SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development

Mei-Yue Wang et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo

Yixuan J. Hou et al.

SCIENCE (2020)

Add to Collection

Article Immunology

Susceptibility of Raccoon Dogs for Experimental SARS-CoV-2 Infection

Conrad M. Freuling et al.

EMERGING INFECTIOUS DISEASES (2020)

Add to Collection

Review Medicine, General & Internal

Gastrointestinal pathophysiology of SARS-CoV2 - a literature review

Anwaruddin Syed et al.

JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES (2020)

Add to Collection

Article Cell Biology

The origin and underlying driving forces of the SARS-CoV-2 outbreak

Shu-Miaw Chaw et al.

JOURNAL OF BIOMEDICAL SCIENCE (2020)

Add to Collection

Article Infectious Diseases

SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental transmission study

Kore Schlottau et al.

LANCET MICROBE (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Molecular Evolution of Human Coronavirus Genomes

Diego Forni et al.

TRENDS IN MICROBIOLOGY (2017)

Add to Collection

Review Biochemistry & Molecular Biology

Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses

Shuo Su et al.

TRENDS IN MICROBIOLOGY (2016)

Add to Collection

Article Virology

Pseudorabies virus can escape from CRISPR-Cas9-mediated inhibition

Zhiyuan Peng et al.

VIRUS RESEARCH (2016)

Add to Collection

© Peeref 2019-2024. All rights reserved.